Chiron collars PowderJect

- Last updated on GMT

Related tags: Influenza vaccine, Chiron

Chiron's has completed its acquisition of UK vaccine and drug
delivery specialist PowderJect, making it the second-largest
manufacturer of flu vaccines worldwide.

Chiron's has completed its $888 million (€782m) acquisition of UK vaccine and drug delivery specialist PowderJect, at a stroke becoming the second-largest manufacturer of influenza vaccines worldwide behind Aventis Pasteur.

The offer was declared unconditional on 7 July after Chiron acquired just under 90 per cent of PowderJect's share capital.

"By leveraging PowderJect's existing infrastructure in the US flu market, Chiron will be able to build on its platform for new products, including our portfolio of meningococcal vaccines that are in development,"​ said the US firm in a statement.

Chiron originally made overtures to PowderJect last autumn, but the UK firm rebuffed its advances on the grounds that the offer made was too low. With the takeover, Chiron gets its hands on Fluvirin, PowderJect's top-selling product, and a fast track into the US flu vaccine business.

The USA has seen significant growth in flu vaccination of late, following the US government's lowering of the threshold for free vaccination from 65 to 50. This helped Fluvirin sales surge 40 per cent to £158 million (€227m) last year.In tandem with its vaccines business, PowderJect is developing both disposable and reusable needle-free injector system for drugs that can be formulated as a powder.

Related news

Show more

Related products

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Follow us


View more